Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: A novel folate hydrolase

Urology

Volumn 49, Issue 3 SUPPL., 1997, Pages 104-112

  Heston, Warren D W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYL HYDROLASE; PROSTATE SPECIFIC ANTIGEN;

ALTERNATIVE RNA SPLICING; ANTIGEN DETECTION; ANTIGEN RECOGNITION; CONFERENCE PAPER; HUMAN; METASTASIS POTENTIAL; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN FOLDING;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BASE SEQUENCE; CARBOXYPEPTIDASES; CLONING, MOLECULAR; FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; HYDROLASES; MOLECULAR SEQUENCE DATA; PTEROYLPOLYGLUTAMIC ACIDS;

EID: 0030997985     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00177-5     Document Type: Conference Paper

References (19)

1. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1991.
2. Horoszewicz JS, Kawinski E, and Murphy JP: Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res 7:927-935, 1987.
3. Israeli R, Powell CT, Fair W, and Heston WDW: Molecular cloning of a complimentary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230, 1993.
4. Su S, Fair W, Powell CT, and Heston WDW: Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 55: 1441-1443, 1995.
5. Troyer J, Fang Q, Beckett ML, and Wright GL Jr: Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate specific membrane antigen. Urol Oncol 1: 29-37, 1995.
6. Israeli RS, Powell CT, Corr JG, Fair WR, and Heston WDW: Expression of the prostate-specific membrane antigen. Cancer Res 54: 1807-1811, 1994.
7. Wright GL Jr, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, and Moriarity R: Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 48: 326-334, 1996.
8. Troyer JK, Beckett ML, and Wright GL Jr: Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 62: 552-558, 1995.
9. Silver DA, Pellicer I, Fair WR, Heston WDW, and Cordon-Cardo C: Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3:81-85, 1997.
10. Chandler CJ, Wang TTY, and Halstead CH: Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. J Biol Chem 261: 928-933, 1986.
11. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May FM, Mukherjee B, and Heston WDW: Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 2: 1445-1451, 1996.
12. Jennings E: Folic acid as a cancer preventing agent. Med Hypotheses 45: 297-303, 1995.
13. Heston WDW: Prostatic polyamines and polyamine targeting as a new approach to the therapy of prostatic cancer. Cancer Surv 11: 217-238, 1991.
14. Jarrard DF, Bova GS, and Isaacs WB: DNA methylation, molecular genetic, and linkage studies in prostate cancer. Prostate 6(suppl): 36-44, 1996.
15. Carter RE, Feldman AR, and Coyle JT: Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA 93: 749-753, 1996.
16. Heston WDW, Silver DA, Pellicer I, Fair WR, and Cordon-Cardo C: Ionotropic glutamate receptor distribution in prostate tissue (abst 809). J Urol 155:513A, 1996.
17. Papandreou P, Freeman R, Xu Y, Scheinberg D, Maslak P, and Scher HI: Neutral endopeptidase regulation by androgen in prostate cancer cells (abst). Proc Amer Assoc Cancer Res 37: 244, 1996.
18. Murphy GP, Tino WT, Holmes EH, Boynton AL, Erickson SJ, Bowes VA, Barren RJ, Tjoa BA, Misrock SL, Ragde H, and Kenny GM: Measurement of prostate-specific membrane antigen in the serum with a new antibody. Prostate 28: 266-271, 1996.
19. Tjoa B, Boynton A, Kenny G, Ragde H, Misrock SL, and Murphy GP: Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity. Prostate 28: 65-69, 1996.